STAT+: Kite to buy Tmunity Therapeutics, Carl June’s troubled CAR-T startup
Kite Pharma, Gilead’s cell therapy subsidiary, said on Tuesday it would buy Tmunity, a biotech…
Category: Cancer Briefing
STAT+: Multiple myeloma is usually detected late. Some researchers think a precursor could help catch it early
For all the recent advances in treating multiple myeloma, scientists have only inched forward in…